Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
EV/Core EBITDA

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 9.399.0815.149.6951.09

What is the latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE ?

The latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE is 9.39 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20269.39
Mar20259.08
Mar202415.14
Mar20239.69
Mar202251.09

How is EV/Core EBITDA of STRIDES PHARMA SCIENCE Trending?

Years EV/Core EBITDA % Change
Mar2026 9.39
3.41
Mar2025 9.08
-40.03
Mar2024 15.14
56.24
Mar2023 9.69
-81.03
Mar2022 51.09 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare EV/Core EBITDA ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,987.1 Cr -0.2% -8.5% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-0.2%

-8.5%

31.8%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses